A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...

A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...

GSK on Tuesday said Japan’s Ministry of Health, Labour and Welfare approved Exdensur, also known as depemokimab, for patients with bronchial asthma whose symptoms cannot be controlled with existing ...

The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, ...

Studies show that smell loss with age may reflect more serious underlying problems, and is even linked to how long we're ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

In the slopocalypse of 2026, there’s a lot of fake news floating around about diet. Those talk-to-camera videos of shirtless ...

Polar bears aren't white, strawberries aren't berries and the Earth isn't round—we'll have you rethinking everything you thought you knew! Mind-blowing facts you have to read to believe Did you know ...

GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...

Blocked Nose Home Remedies: Nose clocked, also known as nasala congestion in medical terms, is a common health problem for many during the winter. From making simple breathing a challenging task to ...

Kendall Jenner recently commented on the plastic surgery rumors that surround her -- and she addressed her changing nose ...